Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0004303 | HP:0004303 | Abnormal muscle fiber morphology | 0 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100298 | Motheaten muscle fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003805 | Rimmed vacuoles | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100293 | Muscle fiber hypertrophy | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030362 | Reduced muscle carnitine level | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0033684 | Abnormal muscle fiber-type distribution | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003791 | Deposits immunoreactive to beta-amyloid protein | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0031542 | Myelin-like whorls in vacuolated fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0012269 | Abnormal muscle glycogen content | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003200 | Ragged-red muscle fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003687 | Centrally nucleated skeletal muscle fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003555 | Muscle fiber splitting | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100296 | Perifascicular muscle fiber atrophy | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0012084 | Abnormality of skeletal muscle fiber size | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030230 | Central core regions in muscle fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003713 | Muscle fiber necrosis | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0009058 | Increased muscle lipid content | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100295 | Muscle fiber atrophy | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100305 | Ring fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0020201 | Abnormal sarcomere morphology | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100299 | Muscle fiber inclusion bodies | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030089 | Abnormal muscle fiber protein expression | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003736 | Autophagic vacuoles | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100297 | Increased endomysial connective tissue | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0031238 | Necklace skeletal muscle fibers | 1 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030228 | Abnormal muscle fiber valosin-containing protein | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003755 | Type 1 fibers relatively smaller than type 2 fibers | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030103 | Abnormal muscle fiber beta sarcoglycan | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030104 | Abnormal muscle fiber gamma sarcoglycan | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030119 | Abnormal muscle fiber calpain-3 | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0012240 | Increased intramyocellular lipid droplets | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030123 | Abnormal muscle fiber lamin A/C | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003554 | Type 2 muscle fiber atrophy | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030090 | Abnormal muscle fiber merosin expression | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030113 | Abnormal muscle fiber dysferlin | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100303 | Muscle fiber cytoplasmatic inclusion bodies | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003557 | Increased variability in muscle fiber diameter | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030122 | Reduced muscle fiber perlecan | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0010602 | Type 2 muscle fiber predominance | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0009051 | Increased muscle glycogen content | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030105 | Abnormal muscle fiber delta sarcoglycan | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0011807 | Type 1 muscle fiber atrophy | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0020202 | Abnormal Z disc morphology | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0025200 | Muscle fiber actin filament accumulation | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030226 | Abnormal muscle fiber myotilin | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030112 | Abnormal muscle fiber alpha dystroglycan | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030096 | Abnormal muscle fiber dystrophin expression | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030095 | Reduced muscle collagen VI | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003803 | Type 1 muscle fiber predominance | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0012270 | Decreased muscle glycogen content | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030093 | Abnormal muscle fiber laminin beta 1 | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030224 | Abnormal muscle fiber desmin | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0031237 | Internally nucleated skeletal muscle fibers | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030100 | Abnormal muscle fiber alpha sarcoglycan | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030116 | Abnormal muscle fiber emerin | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100304 | Muscle fiber intranuclear inclusion bodies | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0033685 | Fiber type grouping | 2 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030120 | Absent muscle fiber calpain-3 | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030124 | Reduced muscle fiber lamin A/C | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030232 | Increased sarcoplasmic glycogen | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030111 | Reduced muscle fiber delta sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030091 | Absent muscle fiber merosin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0020203 | Z-band streaming | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030114 | Absent muscle fiber dysferlin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100300 | Desmin bodies | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030099 | Reduced muscle fiber alpha dystroglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030098 | Reduced muscle dystrophin expression | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0003798 | Nemaline bodies | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030231 | Glycogen accumulation in muscle fiber lysosomes | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030110 | Absent muscle fiber delta sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0033008 | Increased Z-disc width | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030227 | Accumulation of muscle fiber myotilin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030046 | Hypoglycosylation of alpha-dystroglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030097 | Absent muscle dystrophin expression | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100302 | Muscle fiber tubuloreticular inclusions | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030102 | Reduced muscle fiber alpha sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030118 | Reduced muscle fiber emerin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030108 | Reduced muscle fiber gamma sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030094 | Reduced muscle fiber laminin beta 1 | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030225 | Accumulation of muscle fiber desmin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100301 | Muscle fiber tubular inclusions | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030101 | Absent muscle fiber alpha sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030117 | Absent muscle fiber emerin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030107 | Reduced muscle fiber beta sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030121 | Reduced muscle fiber calpain-3 | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030092 | Reduced muscle fiber merosin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030115 | Reduced muscle fiber dysferlin | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0100306 | Muscle fiber hyaline bodies | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030229 | Accumulation of muscle fiber valosin-containing protein | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030106 | Absent muscle fiber beta sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HP:0004303 | HP:0030109 | Absent muscle fiber gamma sarcoglycan | 3 | CAV3 CL E G H | 859 | 123320 | Elevated serum creatine phosphokinase | 123320 | C0241005 | OMIM | 1 | | 417 | 1529 | 601253 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0004303 | HP:0004303 | Abnormal muscle fiber morphology | 0 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100295 | Muscle fiber atrophy | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100305 | Ring fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0020201 | Abnormal sarcomere morphology | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100299 | Muscle fiber inclusion bodies | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030089 | Abnormal muscle fiber protein expression | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003736 | Autophagic vacuoles | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100297 | Increased endomysial connective tissue | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0031238 | Necklace skeletal muscle fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003805 | Rimmed vacuoles | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100293 | Muscle fiber hypertrophy | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030362 | Reduced muscle carnitine level | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0033684 | Abnormal muscle fiber-type distribution | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003791 | Deposits immunoreactive to beta-amyloid protein | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0031542 | Myelin-like whorls in vacuolated fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0012269 | Abnormal muscle glycogen content | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100298 | Motheaten muscle fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003687 | Centrally nucleated skeletal muscle fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003555 | Muscle fiber splitting | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003200 | Ragged-red muscle fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0012084 | Abnormality of skeletal muscle fiber size | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030230 | Central core regions in muscle fibers | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003713 | Muscle fiber necrosis | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0009058 | Increased muscle lipid content | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100296 | Perifascicular muscle fiber atrophy | 1 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030093 | Abnormal muscle fiber laminin beta 1 | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030224 | Abnormal muscle fiber desmin | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0031237 | Internally nucleated skeletal muscle fibers | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030100 | Abnormal muscle fiber alpha sarcoglycan | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030116 | Abnormal muscle fiber emerin | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100304 | Muscle fiber intranuclear inclusion bodies | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0033685 | Fiber type grouping | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0012270 | Decreased muscle glycogen content | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030228 | Abnormal muscle fiber valosin-containing protein | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003755 | Type 1 fibers relatively smaller than type 2 fibers | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030103 | Abnormal muscle fiber beta sarcoglycan | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030104 | Abnormal muscle fiber gamma sarcoglycan | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003554 | Type 2 muscle fiber atrophy | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030090 | Abnormal muscle fiber merosin expression | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030113 | Abnormal muscle fiber dysferlin | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100303 | Muscle fiber cytoplasmatic inclusion bodies | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003557 | Increased variability in muscle fiber diameter | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030122 | Reduced muscle fiber perlecan | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0010602 | Type 2 muscle fiber predominance | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030119 | Abnormal muscle fiber calpain-3 | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0012240 | Increased intramyocellular lipid droplets | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030123 | Abnormal muscle fiber lamin A/C | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030105 | Abnormal muscle fiber delta sarcoglycan | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0011807 | Type 1 muscle fiber atrophy | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0020202 | Abnormal Z disc morphology | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0025200 | Muscle fiber actin filament accumulation | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030226 | Abnormal muscle fiber myotilin | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030112 | Abnormal muscle fiber alpha dystroglycan | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030096 | Abnormal muscle fiber dystrophin expression | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030095 | Reduced muscle collagen VI | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003803 | Type 1 muscle fiber predominance | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0009051 | Increased muscle glycogen content | 2 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030092 | Reduced muscle fiber merosin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030115 | Reduced muscle fiber dysferlin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100306 | Muscle fiber hyaline bodies | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030229 | Accumulation of muscle fiber valosin-containing protein | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030106 | Absent muscle fiber beta sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030109 | Absent muscle fiber gamma sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030121 | Reduced muscle fiber calpain-3 | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030124 | Reduced muscle fiber lamin A/C | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030232 | Increased sarcoplasmic glycogen | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030111 | Reduced muscle fiber delta sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030091 | Absent muscle fiber merosin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0020203 | Z-band streaming | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030114 | Absent muscle fiber dysferlin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100300 | Desmin bodies | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030099 | Reduced muscle fiber alpha dystroglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030098 | Reduced muscle dystrophin expression | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0003798 | Nemaline bodies | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030120 | Absent muscle fiber calpain-3 | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030231 | Glycogen accumulation in muscle fiber lysosomes | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030110 | Absent muscle fiber delta sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0033008 | Increased Z-disc width | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030227 | Accumulation of muscle fiber myotilin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030046 | Hypoglycosylation of alpha-dystroglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030097 | Absent muscle dystrophin expression | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100302 | Muscle fiber tubuloreticular inclusions | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030102 | Reduced muscle fiber alpha sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030118 | Reduced muscle fiber emerin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030094 | Reduced muscle fiber laminin beta 1 | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030225 | Accumulation of muscle fiber desmin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0100301 | Muscle fiber tubular inclusions | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030101 | Absent muscle fiber alpha sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030117 | Absent muscle fiber emerin | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030107 | Reduced muscle fiber beta sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |
HP:0004303 | HP:0030108 | Reduced muscle fiber gamma sarcoglycan | 3 | GLI3 CL E G H | 2737 | 175700 | Greig cephalopolysyndactyly syndrome | 175700 | C0265306 | OMIM | 0 | | 981 | 4319 | 165240 |